NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) Insurtech Insights USA 2024, the premier gathering for innovators and leaders in the insurance technology industry, kicked off today at the Javits
Grail announced a step that may help move the company closer to securing Medicare reimbursement for its Galleri multicancer blood test, sold in the US since 2021.